These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33665885)

  • 41. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study.
    Kong SH; Suh HS; Choi YS
    Ann Dermatol; 2018 Feb; 30(1):1-7. PubMed ID: 29386825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial.
    Shin JU; Park J; Oh SH; Lee JH
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):435-42. PubMed ID: 23278870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
    Lai D; Zhou S; Cheng S; Liu H; Cui Y
    Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
    Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
    Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser.
    Lee WJ; Kim YJ; Noh TK; Chang SE
    J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined vitamin C sonophoresis and neodymium-doped yttrium aluminum garnet (NdYAG) laser for facial hyperpigmentation: An outcome observation study in Asian patients.
    Chen YT; Chang CC; Hsu CR; Shen JH; Shih CJ; Lin BS
    Indian J Dermatol Venereol Leprol; 2016; 82(5):587. PubMed ID: 27212284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Q-Switched Laser Combined with Intense Pulsed Laser in the Treatment of Melasma Based on Reflection Confocal Microscope.
    Xu J; Pu Y
    Comput Math Methods Med; 2022; 2022():4413130. PubMed ID: 35813427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety.
    Karn D; K C S; Amatya A; Razouria EA; Timalsina M; Suwal A
    Kathmandu Univ Med J (KUMJ); 2012; 10(38):46-50. PubMed ID: 23132475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single and combined 1064 nm Q-switched Nd: YAG laser therapy in melasma: A meta-analysis.
    Zhang B; Xie B; Shen Y; Zhang L; Song X
    J Cosmet Dermatol; 2022 Sep; 21(9):3794-3802. PubMed ID: 35876484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis.
    Ren R; Bao S; Qian W; Zhao H
    Dermatol Surg; 2023 May; 49(5S):S49-S55. PubMed ID: 37116000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lasers for treatment of melasma and post-inflammatory hyperpigmentation.
    Arora P; Sarkar R; Garg VK; Arya L
    J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma.
    Kar HK; Gupta L; Chauhan A
    Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal grafting for leukoderma resulting from 1064-nm quality-switched neodymium-doped yttrium aluminium garnet laser toning.
    Wang YJ; Chang CC
    Int Wound J; 2018 Dec; 15(6):1045-1048. PubMed ID: 30014596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.